Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

A Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in China

Phase: N/A Priority: Normal
NCT ID: NCT06101316 Org: User:
Start: 09/19/23 End: 12/29/23 Due: 12/29/24

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants in Australia

Phase: N/A Priority: Normal
NCT ID: NCT05502549 Org: User:
Start: 11/29/22 End: 12/15/23 Due: 12/15/24

A Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Doses in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04220801 Org: User:
Start: 02/17/20 End: 11/18/20 Due: 11/18/21

A Multiple-dose Study in Chinese Subjects to Evaluate Safety,Tolerability,PK and PD of ZM-H1505R

Phase: N/A Priority: Normal
NCT ID: NCT05470829 Org: User:
Start: 05/27/21 End: 11/17/21 Due: 11/17/22

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05499260 Org: User:
Start: 05/02/22 End: 03/02/23 Due: 03/02/24

A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB

Phase: N/A Priority: Normal
NCT ID: NCT05484466 Org: User:
Start: 11/11/22 End: 12/30/24 Due: 12/30/25

A Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 in Adult Patients With Focal Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT06612775 Org: User:
Start: 09/30/24 End: 09/30/26 Due: 09/30/27

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT05828745 Org: User:
Start: 04/22/24 End: 02/18/25 Due: 02/18/26